Viewing StudyNCT01324232



Ignite Creation Date: 2024-05-05 @ 11:25 PM
Last Modification Date: 2024-10-26 @ 10:33 AM
Study NCT ID: NCT01324232
Status: COMPLETED
Last Update Posted: 2021-11-22
First Post: 2011-03-23

Brief Title: Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Sponsor: Avanir Pharmaceuticals
Organization: Avanir Pharmaceuticals

Organization Data

Organization: Avanir Pharmaceuticals
Class: INDUSTRY
Study ID: 11-AVR-130
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Avanir Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators